Masamitsu Mikami
2PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Dec 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani
Pageof 1
Frequent Collaborators
1 joint publications
Hiroshi Mizumoto
1 joint publications
Katsutsugu Umeda
1 joint publications
Hidefumi Hiramatsu
1 joint publications
Hirohito Kubota
1 joint publications
Tomoo Daifu
1 joint publications
Etsuko Yamamoto Hattori
1 joint publications
Hidemasa Matsuo
1 joint publications
Tatsuki R Kataoka
1 joint publications
Tatsutoshi Nakahata
1 joint publications
Yasumichi Kuwahara
